NEW YORK (360Dx) – Grifols announced today that its antigen supply arrangement with OraSure Technologies has been extended.

Under the terms of the extended agreement, Grifols will supply antigens for OraSure's OraQuick HCV Rapid Antibody test, which is approved for qualitatively detecting hepatitis C virus antibodies in whole blood obtained through the use of a fingerstick or venipuncture. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.